MHA

Quanta™ Announces Enrollment Completion in Home Run Study

Retrieved on: 
Thursday, August 17, 2023
Quanta, FASN, Kidney disease, FRCPC, FDA, Home run, Patient, MHA, Safety, Medical device

BEVERLY, Mass., Aug. 17, 2023 /PRNewswire/ -- Quanta Dialysis Technologies® today announced that it has completed enrollment of its Home Run study for at-home hemodialysis. The Home Run study is a prospective, multi-center, open-label trial to assess the efficacy and safety of the Quanta Dialysis System for home hemodialysis. Results are expected to be announced in the second half of 2023.

Key Points: 
  • BEVERLY, Mass., Aug. 17, 2023 /PRNewswire/ -- Quanta Dialysis Technologies® today announced that it has completed enrollment of its Home Run study for at-home hemodialysis.
  • The Home Run study is a prospective, multi-center, open-label trial to assess the efficacy and safety of the Quanta Dialysis System for home hemodialysis.
  • Results are expected to be announced in the second half of 2023.
  • Enrollment completion is the first step forward in a potential new alternative for people with this life-threatening disease."

MGMA Report Details Financial Impact of Staffing Crisis on Medical Groups

Retrieved on: 
Monday, August 7, 2023
Medicine, CAE, Cost of revenue, FACMPE, Organization, Hospital, Patient, FTE, MHA, Nursing

ENGLEWOOD, Colo., Aug. 7, 2023 /PRNewswire/ -- Medical Group Management Association (MGMA) released a new report that sheds light on the financial obstacles faced by medical groups due to staffing shortages. These challenges impacting the bottom line of medical practices are further compounded as patients struggle to stretch their budgets in an era of inflated expenses in their everyday lives. Despite these challenges, medical groups are proactively seeking innovative staffing solutions to continue delivering quality care.

Key Points: 
  • ENGLEWOOD, Colo., Aug. 7, 2023 /PRNewswire/ -- Medical Group Management Association (MGMA) released a new report that sheds light on the financial obstacles faced by medical groups due to staffing shortages.
  • Despite these challenges, medical groups are proactively seeking innovative staffing solutions to continue delivering quality care.
  • As part of the industry leading MGMA DataDive, the 2023 MGMA DataDive Cost and Revenue report reflects data from more than 4,000 organizations spanning a variety of specialties and practice types.
  • MGMA DataDive benchmarks show hospital-owned practices returning to pre-pandemic levels in medical revenue, but physician-owned practices reported across-the-board declines in 2022.

Quanta™ Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies

Retrieved on: 
Thursday, August 3, 2023
Quanta, IHD, Biochemistry, SLED, Nursing, Hospital, Food and Drug Administration, Mortality, AKI, Dialysis, Kidney disease, Acute kidney injury, CRRT, Nephrology, Patient, FASN, Hemofiltration, ICU, FRCPC, ESKD, TKT, FDA, Society, MHA, Food, Software, Medical device

BEVERLY, Mass., Aug. 3, 2023 /PRNewswire/ -- Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device, for two modalities of continuous renal replacement therapy (CRRT): continuous venovenous hemodialysis (CVVHD) and slow continuous ultrafiltration (SCUF). Under the new 510(k), the Quanta Dialysis System is the only dialysis device FDA-cleared to provide intermittent hemodialysis (IHD), sustained low efficiency dialysis (SLED) or bagless CRRT which creates dialysate on demand – all in a single machine.

Key Points: 
  • The Quanta Dialysis System is the only dialysis device FDA-cleared to perform IHD, SLED or CRRT - all in a one platform.
  • The Quanta Dialysis System was originally designed to serve the more than two million people with end-stage kidney disease (ESKD) worldwide who receive treatment with dialysis or a kidney transplant.
  • It features dialysate flow rates from 50 to 500 mL/min and treatment times up to 24 hours of continuous delivery.
  • "This clearance is a true game-changer for acute care settings," said Quanta Chief Executive Officer, Alejandro Galindo.

PointClickCare Expands its Network throughout Massachusetts, Improving Interoperability Between Healthcare Entities

Retrieved on: 
Wednesday, August 2, 2023
Nursing, Mental Health, Health, Hospitals, Health Technology, Health Insurance, SBP, Communication, Medical Affairs Bureau, Partnership, Senior, Policy, BH, Mental health, Intelligence, General number field sieve, Ontario Hospital Association, Ambulatory care, Hospital, Massachusetts Executive Office of Health and Human Services, Patient, Automation, FACEP, Massachusetts health care reform, Oklahoma Department of Mental Health and Substance Abuse Services, Ecosystem, Commonwealth, SVP, MHA, Caregiver, Accountable care organization, MD

“Investment in technology is an important way of improving coordination of patient care,” said Valerie Fleishman , Senior Vice President and Chief Innovation Officer at the Massachusetts Health & Hospital Association.

Key Points: 
  • “Investment in technology is an important way of improving coordination of patient care,” said Valerie Fleishman , Senior Vice President and Chief Innovation Officer at the Massachusetts Health & Hospital Association.
  • As a strong investment in patient-centric technology, PointClickCare will be added to MHA’s Strategic Business Partner (SBP) program.
  • Specifically, the collaboration will provide participating Massachusetts hospitals and health systems with real‐time insights to support high-risk patients across the healthcare continuum.
  • To learn more about how PointClickCare is improving care collaboration, visit our website here .

The Advanced Leadership Institute and Carnegie Mellon University Celebrate the Graduation of the 2023 Executive Leadership Academy Cohort

Retrieved on: 
Thursday, July 20, 2023
Dollar Bank, Human resources, Partnership, Wabtec, Senior, Operational definition, China Executive Leadership Academy in Pudong, PNC, Ambulatory, Woman, Internal audit, FSB, MHI, Carnegie Mellon University, Medical Center, University of Pittsburgh Medical Center, Freddie Mac, Helsinki University Central Hospital, Student, CMU, Leadership Academy, MHA, Dean (education), Management, Audit, Business

PITTSBURGH, July 20, 2023 /PRNewswire/ -- On Friday, July 21, 2023, 26 impressive Black leaders will graduate from The Advanced Leadership Institute's (TALI) Executive Leadership Academy.

Key Points: 
  • PITTSBURGH, July 20, 2023 /PRNewswire/ -- On Friday, July 21, 2023, 26 impressive Black leaders will graduate from The Advanced Leadership Institute's (TALI) Executive Leadership Academy.
  • The Executive Leadership Academy, delivered in partnership with Carnegie Mellon University Tepper School of Business (CMU), is TALI's signature program.
  • This seven-module program includes instruction from renowned academic and industry experts, executive coaching, and executive mentoring where each participant is paired with a distinguished executive for hands-on guidance throughout the Academy.
  • "The graduation of the 2023 Executive Leadership Academy cohort marks five successful years of our signature program," says Evan Frazier, President and CEO, The Advanced Leadership Institute, "Every year, we are encouraged and inspired by the wealth of Black talent that comes through TALI.

Castle Biosciences to Host Second Annual Castle Cares Charity Walk

Retrieved on: 
Tuesday, July 18, 2023
Mental Health, Entertainment, Philanthropy, Events, Concerts, Biotechnology, Health, Fund Raising, Pharmaceutical, Oncology, Clifford Whittingham Beers, Skin Cancer Foundation, Melanoma, Organization, Melody of Certain Damaged Lemons, ECAN, ACIS, MHA, Pharmaceutical industry

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, announced that it will host its second company-wide Castle Cares Charity Walk today, Tuesday, July 18, 2023, in Orlando, Florida, and virtually.

Key Points: 
  • Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, announced that it will host its second company-wide Castle Cares Charity Walk today, Tuesday, July 18, 2023, in Orlando, Florida, and virtually.
  • “The Castle Cares Charity Walk serves as a testament to our employees’ dedication and the values we uphold as an organization.
  • I am incredibly proud of our Castle team and the great work they are doing in support of these remarkable organizations.”
    The 2022 inaugural Castle Cares Charity Walk raised more than $11,000 for partner organizations, a goal which the Company endeavors to exceed this year.
  • Learn more about the organizations Castle is supporting through its walk at the following websites: The Skin Cancer Foundation , IMPACT Melanoma , Esophageal Cancer Action Network (ECAN) , Mental Health America (MHA) and A Cure in Sight .

In the Wake of a New Report on Diagnostic Errors, Society to Improve Diagnosis in Medicine (SIDM) Invites Collaboration and Policy Action

Retrieved on: 
Monday, July 17, 2023
Learning, Society, Education, Capitol Hill, National Academies of Sciences, Engineering, and Medicine, Infection, Hill, Doctor of Philosophy, Diagnosis, Gordon, Congress, Malpractice, National academy, Hospital, Patient, Patient safety, Risk, Cancer, SIDM, Disease, Risk management, Mortality, AHRQ, John A. Hartford Foundation, BMJ Quality & Safety, Capitol, MPH, Physician, MHA, Medical device, Engineering, Medicine, MD

The study estimates that between 600,000 and 1 million patients suffer from permanent disability or die each year due to diagnostic errors.

Key Points: 
  • The study estimates that between 600,000 and 1 million patients suffer from permanent disability or die each year due to diagnostic errors.
  • This new report underscores the salience of the issue and demands further collaborative action to expand investment in the field.
  • "When new data on diagnostic error emerges, industry leaders and policymakers should focus their energy on learning and funding opportunities to improve diagnosis.
  • The Society to Improve Diagnosis in Medicine (SIDM) believes there is hope for alleviating risk and achieving excellence in diagnosis.

New Fisher House Dedicated at the Columbia Missouri Veterans Affairs Health Care System

Retrieved on: 
Friday, July 14, 2023
Enterprise Rent-A-Car, Partnership, DNS, Diplomatic Reception Rooms, U.S. Department of State, Veterans Health Administration, Health, Coker, Friends, Love, Fisher House Foundation, Medical Center, Fisher House, Veterans' affairs, United Kingdom, Hospital, U.S. Department of Veterans Affairs, Office of Inspector General, Caregiver, House, MHA, FAAN, Real estate, United Rentals, Veteran

The Mid-Missouri Fisher House will provide a no-cost home away from home option for the families and caregivers of hospitalized Veterans receiving treatment at the Columbia VA medical center.

Key Points: 
  • The Mid-Missouri Fisher House will provide a no-cost home away from home option for the families and caregivers of hospitalized Veterans receiving treatment at the Columbia VA medical center.
  • This is the third VA Fisher House in Missouri, joining one in St. Louis and another in Kansas City.
  • “The Mid-Missouri Fisher House is a beautiful addition to our Columbia campus and an extension of the love and support we provide each day.”
    Mid-Missouri is the 95th Fisher House in operation as Fisher House Foundation continues on its “Road to 100” Fisher Houses.
  • Fisher House Foundation proudly recognizes the generosity of the following contributors for their extraordinary support of our military and veteran families: Veterans United Foundation, United Rentals, Friends of Mid-Missouri Fisher House, Enterprise Rent-A-Car, Greater Kansas City Friends of Fisher House, Vehicles for Veterans, and the many gifts of a grateful nation.

MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources

Retrieved on: 
Thursday, July 13, 2023
Epic Systems, Patient satisfaction, Texas Health Resources, THR, Patient, Epic, MHA, Hospital

PHOENIX, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today it has successfully achieved integration between MedAvail’s Remote Dispensing System® and its largest partner, Texas Health Resources.

Key Points: 
  • PHOENIX, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today it has successfully achieved integration between MedAvail’s Remote Dispensing System® and its largest partner, Texas Health Resources.
  • “In parallel, we continue to work on additional integration interfaces, assisted by our new development partner, Encora, that will make future MedCenter deployments fast and seamless for our current and prospective hospital and clinic partners.”
    “This enhanced integration between the MedCenter and our network of urgent care clinics has decreased overall patient dispensing wait times,” stated Bianca Randall, MHA, Director of Pharmacy Operations at Texas Health Resources, MedAvail’s largest customer.
  • For other prospective partners who utilize the Epic Willow Ambulatory PMS, the MedAvail Remote Dispensing System integration is available for download through the open.epic download page here .
  • Approximately 25% of MedAvail’s current sales pipeline utilizes the Epic PMS.

Hampton Groover, MD, Named Chief Medical Officer at Haven

Retrieved on: 
Thursday, July 13, 2023
Atlanta Medical Center, Central Florida, Bachelor of Science, University, Augusta University, Internal medicine, Medical college, Medical College of Georgia, Nursing, Medical director, MD, Palliative care, Hospice, Biology, RN, MHA, Health system, Science

GAINESVILLE, Fla., July 13, 2023 /PRNewswire/ -- Hampton Groover, MD, has been named Chief Medical Officer of Haven, North Central Florida's legacy mission-driven provider of hospice and palliative care. With a career that includes working in hospice and palliative care—as well as extensive academic experience—Dr. Groover brings years of relevant experience to Haven.

Key Points: 
  • GAINESVILLE, Fla., July 13, 2023 /PRNewswire/ -- Hampton Groover, MD, has been named Chief Medical Officer of Haven, North Central Florida's legacy mission-driven provider of hospice and palliative care.
  • As Chief Medical Officer, Dr. Groover serves as a member of senior leadership and oversees Haven's team of skilled providers across its 18-county service area.
  • "It is a privilege to welcome such an esteemed professional as our new Chief Medical Officer," noted Haven President and Chief Operating Officer Pauline Taylor, RN, MHA.
  • Dr. Groover came to Haven from St. Mary's Health Care System, Athens, Ga., where he served as Medical Director of its inpatient palliative medicine program.